Relling, Mary V.
https://orcid.org/0000-0002-3720-9591
Mayo Clinic
St. Jude Children's Research Hospital
Citations 13
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting
Kalman, LV, Agúndez, JAG, Appell, Malin Lindqvist , Black, J.H., Bell, GC, Boukouvala, Sotiria , Bruckner, Carsten, Bruford, Elspeth A. , Caudle, KE, Coulthard, SA, Daly, Ann K. , Tredici, AL Del, Dunnen, Johan T. den , Drozda, Katarzyna, Everts, Robin E. , Flockhart, David A., Freimuth, Robert R. , Hachad, Houda , Hartshorne, Toinette, Ingelman‐Sundberg, Magnus , Klein, Teri E. , Lauschke, Volker M. , Maglott, DR, McLeod, HL, McMillin, GA, Ua, Meyer, Dj, Müller, Nickerson, D. A., Oetting, WS , Pacanowski, MA, Vm, Pratt, Relling, MV, Roberts, Angharad M. , Ws, Rubinstein, Sangkuhl, Katrin , Schwab, Matthias , Scott, Stuart A. , Sim, SC, Thirumaran, RK, Toji, LH, Tyndale, Rachel F. , Schaik, RHN van, Whirl‐Carrillo, Michelle , Yeo, K. L. B., Zanger, UM, Agúndez, José A. G. , Müller, Daniel J. , Agúndez, JAG, Gaedigk, Andrea , Relling, Mary V. , Toji, Lorraine H., Whirl-Carrillo, Michelle , Agúndez, José A G , Hachad, Houda , Müller, Daniel J , Tyndale, Rachel F , Freimuth, Robert R , Klein, Teri E , Scott, Stuart A , Schwab, Matthias
Clinical Pharmacology & Therapeutics | October 20, 2015 | Volume: 99 | Issue: 2 | Pages: 172-185
This article provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described using different nomenclature systems. In addition, PGx analysis may detect different sets of variants for each gene, which can affect interpretation of results. This practice has caused confusion and may thereby impede the adoption of clinical PGx testing. Standardization is critical to move PGx forward.
A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults
Pérez-Andreu, Virginia, Zhang, Hui , Harvey, Richard C. , Payne-Turner, Debbie , Cheng, I-Ming, Carroll, William L. , Heerema, Nyla A. , Carroll, Andrew J. , Raetz, Elizabeth A. , Marcucci, Guido , Bloomfield, Clara D. , Mrózek, Krzysztof , Kohlschmidt, Jessica, Konopleva, Marina , Paietta, Elisabeth , Rowe, Jacob M. , Luger, Selina M. , Tallman, Martin S. , Dean, Michael , Torgerson, Dara G., Wang, Yanli , Relling, Mary V. , Evans, William E. , Gerhard, Daniela S., Loh, Mignon L. , Mullighan, Charles G. , Roberts, Kathryn G. , Xu, Heng Yi , Smith, Colton J. , Yang, Wenjian , Devidas, Meenakshi , Gastier‐Foster, Julie M. , Stock, Wendy , Kornblau, Steven M. , Burchard, Esteban G. , Yue, Feng , Pui, Ching-Hon , Jeha, Sima , Willman, Cheryl L. , Hunger, Stephen P. , Yang, Jun J.J. , Mullighan, Charles G , Harvey, Richard , Loh, Mignon L , Dean, Michael
Blood | December 3, 2014 | Volume: 125 | Issue: 4 | Pages: 680-686
Key PointsIn this first ALL GWAS in AYAs, we determined that inherited GATA3 variants strongly influence ALL susceptibility in this age group. These findings revealed similarities and differences in the genetic basis of ALL susceptibility between young children and AYAs.
Genetic Nondiscrimination Legislation: A Critical Prerequisite for Pharmacogenomics Data Sharing
Benowitz, Neal L. , Gurwitz, David , Relling, Mary V. , Wieben, Eric D. , Mooney, Sean D. , Johnson, Julie A. , McLeod, Howard L. , Flockhart, David A., Weinshilboum, Richard M. , Shuldiner, Alan R. , Roden, Dan M. , Krauss, Ronald M., Ratain, Mark J. , Altman, Russ B. , Lunshof, Jeantine E. , Lamba, Jatinder Kaur , Giacomini, Kathleen M. , Weiss, Scott T. , Weinshilboum, Richard M. , Roden, Dan M. , Shuldiner, Alan R
Pharmacogenomics | April 27, 2007 | Volume: 8 | Issue: 5 | Pages: 519-519